Imipenem-cilastatin-funobactam versus imipenem-cilastatin-relebactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia: a phase 3, double-blind, non-inferiority randomised trial. (linkinghub.elsevier.com)

Authors: Chang K … Cao B Journal: Lancet Infectious Diseases Published: 2026-11-04 DOI: https://doi.org/10.1016/S1473-3099(26)00520-7